Physician profile
Amy E Ciccio
NPI 1447204441
$967.55
in general payments reported to CMS, 2019-2025
10 companies · $53.60 in 2025
The $53.60 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $121 · 2021: $238 · 2022: $157 · 2023: $55.05 · 2024: $42.40 · 2025: $53.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $151.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $432.45 | 2019-2023 | Clareon |
| Allergan, INC. | $98.48 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $94.32 | 2020-2021 | |
| Rxsight INC | $66.53 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Abbvie INC. | $65.95 | 2024-2025 | |
| The Cameron-Ehlen Group, INC. | $62.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $61.43 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $40.30 | 2021-2022 | |
| Glaukos Corporation | $29.32 | 2021-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Optos, INC. | $16.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Ciccio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.